Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic-Reference-Cited by-同舟云学术

Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic

Published:2021-02-04 Issue:4 Volume:64 Page:2110-2124
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chartier Magali¹,Desgagné Michael¹,Sousbie Marc¹,Côté Jérôme¹,Longpré Jean-Michel¹,Marsault Eric¹^ORCID,Sarret Philippe¹^ORCID

Affiliation:

1. Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada

Funder

Canadian Institutes of Health Research

Fonds de Recherche du Québec - Santé

Canada Foundation for Innovation

Natural Sciences and Engineering Research Council of Canada

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01726

Reference107 articles.

1. Opioids for Chronic Pain: New Evidence, New Strategies, Safe Prescribing

2. Extended-release morphine sulfate in treatment of severe acute and chronic pain

3. Opioid analgesia: recent developments

4. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and In Vitro Characterization of Proteolytically-Stable Opioid-Neurotensin Hybrid Peptidomimetics;ACS Pharmacology & Translational Science;2024-08-19

2. Insights on Structure–Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles;Journal of Medicinal Chemistry;2024-02-28

3. Encounter Complexes Between the N-terminal of Neurotensin with the Extracellular Loop 2 of the Neurotensin Receptor 1 Steer Neurotensin to the Orthosteric Binding Pocket;Journal of Molecular Biology;2023-10

4. Neurotensin(8–13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease;European Journal of Medicinal Chemistry;2023-06

5. Opening the amino acid toolbox for peptide‐based NTS2‐selective ligands as promising lead compounds for pain management;Journal of Peptide Science;2023-01-11